nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ABCB1—ovarian cancer	0.296	1	CbGaD
Prednisone—SLCO1A2—Chlorambucil—ovarian cancer	0.24	0.542	CbGbCtD
Prednisone—ABCB1—Topotecan—ovarian cancer	0.0449	0.101	CbGbCtD
Prednisone—ABCB1—Vinorelbine—ovarian cancer	0.0316	0.0715	CbGbCtD
Prednisone—CYP3A4—Topotecan—ovarian cancer	0.0269	0.0608	CbGbCtD
Prednisone—ABCB1—Paclitaxel—ovarian cancer	0.0222	0.0502	CbGbCtD
Prednisone—CYP3A4—Vinorelbine—ovarian cancer	0.019	0.0428	CbGbCtD
Prednisone—ABCB1—Docetaxel—ovarian cancer	0.0161	0.0363	CbGbCtD
Prednisone—CYP3A4—Paclitaxel—ovarian cancer	0.0133	0.0301	CbGbCtD
Prednisone—ABCB1—Doxorubicin—ovarian cancer	0.012	0.0271	CbGbCtD
Prednisone—CYP3A4—Docetaxel—ovarian cancer	0.00963	0.0218	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—ovarian cancer	0.00718	0.0162	CbGbCtD
Prednisone—HSD11B1—myometrium—ovarian cancer	0.00583	0.114	CbGeAlD
Prednisone—HSD11B1—decidua—ovarian cancer	0.00432	0.0844	CbGeAlD
Prednisone—HSD11B1—gonad—ovarian cancer	0.00381	0.0743	CbGeAlD
Prednisone—HSD11B1—uterus—ovarian cancer	0.00378	0.0738	CbGeAlD
Prednisone—HSD11B1—female reproductive system—ovarian cancer	0.0034	0.0663	CbGeAlD
Prednisone—HSD11B1—female gonad—ovarian cancer	0.00309	0.0604	CbGeAlD
Prednisone—HSD11B1—vagina—ovarian cancer	0.00307	0.06	CbGeAlD
Prednisone—HSD11B1—testis—ovarian cancer	0.00274	0.0535	CbGeAlD
Prednisone—HSD11B1—lymph node—ovarian cancer	0.00199	0.0388	CbGeAlD
Prednisone—NR3C1—myometrium—ovarian cancer	0.0011	0.0215	CbGeAlD
Prednisone—NR3C1—embryo—ovarian cancer	0.00106	0.0207	CbGeAlD
Prednisone—NR3C1—epithelium—ovarian cancer	0.000866	0.0169	CbGeAlD
Prednisone—NR3C1—uterine cervix—ovarian cancer	0.000859	0.0168	CbGeAlD
Prednisone—SLCO1A2—testis—ovarian cancer	0.00083	0.0162	CbGeAlD
Prednisone—ALB—testis—ovarian cancer	0.000825	0.0161	CbGeAlD
Prednisone—NR3C1—decidua—ovarian cancer	0.000818	0.016	CbGeAlD
Prednisone—NR3C1—endometrium—ovarian cancer	0.000777	0.0152	CbGeAlD
Prednisone—CYP2C19—vagina—ovarian cancer	0.000744	0.0145	CbGeAlD
Prednisone—NR3C1—gonad—ovarian cancer	0.00072	0.0141	CbGeAlD
Prednisone—NR3C1—uterus—ovarian cancer	0.000716	0.014	CbGeAlD
Prednisone—NR3C1—female reproductive system—ovarian cancer	0.000643	0.0126	CbGeAlD
Prednisone—NR3C1—bone marrow—ovarian cancer	0.000607	0.0119	CbGeAlD
Prednisone—ALB—lymph node—ovarian cancer	0.000598	0.0117	CbGeAlD
Prednisone—ABCB1—myometrium—ovarian cancer	0.000591	0.0115	CbGeAlD
Prednisone—NR3C1—female gonad—ovarian cancer	0.000585	0.0114	CbGeAlD
Prednisone—NR3C1—vagina—ovarian cancer	0.000582	0.0114	CbGeAlD
Prednisone—Danazol—PGR—ovarian cancer	0.000582	0.226	CrCbGaD
Prednisone—ABCB1—embryo—ovarian cancer	0.000568	0.0111	CbGeAlD
Prednisone—NR3C1—testis—ovarian cancer	0.000519	0.0101	CbGeAlD
Prednisone—CYP3A4—female reproductive system—ovarian cancer	0.000487	0.0095	CbGeAlD
Prednisone—Betamethasone—PGR—ovarian cancer	0.000474	0.184	CrCbGaD
Prednisone—ABCB1—epithelium—ovarian cancer	0.000464	0.00905	CbGeAlD
Prednisone—ABCB1—uterine cervix—ovarian cancer	0.00046	0.00897	CbGeAlD
Prednisone—ABCB1—decidua—ovarian cancer	0.000438	0.00855	CbGeAlD
Prednisone—ABCB1—endometrium—ovarian cancer	0.000416	0.00811	CbGeAlD
Prednisone—ABCB1—gonad—ovarian cancer	0.000386	0.00753	CbGeAlD
Prednisone—ABCB1—uterus—ovarian cancer	0.000383	0.00748	CbGeAlD
Prednisone—NR3C1—lymph node—ovarian cancer	0.000376	0.00735	CbGeAlD
Prednisone—Danazol—ESR1—ovarian cancer	0.000367	0.143	CrCbGaD
Prednisone—ABCB1—female reproductive system—ovarian cancer	0.000344	0.00672	CbGeAlD
Prednisone—ABCB1—bone marrow—ovarian cancer	0.000325	0.00635	CbGeAlD
Prednisone—ABCB1—female gonad—ovarian cancer	0.000313	0.00612	CbGeAlD
Prednisone—ABCB1—vagina—ovarian cancer	0.000312	0.00608	CbGeAlD
Prednisone—ABCB1—testis—ovarian cancer	0.000278	0.00542	CbGeAlD
Prednisone—Dexamethasone—PGR—ovarian cancer	0.000276	0.107	CrCbGaD
Prednisone—Dexamethasone—CYP1B1—ovarian cancer	0.000258	0.1	CrCbGaD
Prednisone—ABCB1—lymph node—ovarian cancer	0.000201	0.00393	CbGeAlD
Prednisone—Methylprednisolone—ABCB1—ovarian cancer	0.000184	0.0716	CrCbGaD
Prednisone—Vertigo—Paclitaxel—ovarian cancer	0.000165	0.000965	CcSEcCtD
Prednisone—Syncope—Paclitaxel—ovarian cancer	0.000165	0.000964	CcSEcCtD
Prednisone—Lethargy—Doxorubicin—ovarian cancer	0.000165	0.000963	CcSEcCtD
Prednisone—Rash—Topotecan—ovarian cancer	0.000164	0.000961	CcSEcCtD
Prednisone—Hypersensitivity—Vinorelbine—ovarian cancer	0.000164	0.000961	CcSEcCtD
Prednisone—Dermatitis—Topotecan—ovarian cancer	0.000164	0.00096	CcSEcCtD
Prednisone—Headache—Topotecan—ovarian cancer	0.000163	0.000955	CcSEcCtD
Prednisone—Angiopathy—Docetaxel—ovarian cancer	0.000162	0.000949	CcSEcCtD
Prednisone—Vomiting—Melphalan—ovarian cancer	0.000162	0.000949	CcSEcCtD
Prednisone—Immune system disorder—Docetaxel—ovarian cancer	0.000162	0.000945	CcSEcCtD
Prednisone—Loss of consciousness—Paclitaxel—ovarian cancer	0.000162	0.000945	CcSEcCtD
Prednisone—Osteoarthritis—Doxorubicin—ovarian cancer	0.000161	0.000944	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000161	0.000944	CcSEcCtD
Prednisone—Rash—Melphalan—ovarian cancer	0.000161	0.000941	CcSEcCtD
Prednisone—Dermatitis—Melphalan—ovarian cancer	0.000161	0.00094	CcSEcCtD
Prednisone—Asthenia—Vinorelbine—ovarian cancer	0.00016	0.000936	CcSEcCtD
Prednisone—Dry skin—Epirubicin—ovarian cancer	0.00016	0.000935	CcSEcCtD
Prednisone—Arrhythmia—Docetaxel—ovarian cancer	0.00016	0.000935	CcSEcCtD
Prednisone—Convulsion—Paclitaxel—ovarian cancer	0.000159	0.000931	CcSEcCtD
Prednisone—Affect lability—Doxorubicin—ovarian cancer	0.000159	0.000929	CcSEcCtD
Prednisone—Hypokalaemia—Epirubicin—ovarian cancer	0.000159	0.000928	CcSEcCtD
Prednisone—Hypertension—Paclitaxel—ovarian cancer	0.000159	0.000928	CcSEcCtD
Prednisone—Alopecia—Docetaxel—ovarian cancer	0.000158	0.000925	CcSEcCtD
Prednisone—Pruritus—Vinorelbine—ovarian cancer	0.000158	0.000923	CcSEcCtD
Prednisone—Mental disorder—Docetaxel—ovarian cancer	0.000157	0.000917	CcSEcCtD
Prednisone—Arthralgia—Paclitaxel—ovarian cancer	0.000157	0.000915	CcSEcCtD
Prednisone—Myalgia—Paclitaxel—ovarian cancer	0.000157	0.000915	CcSEcCtD
Prednisone—Anxiety—Paclitaxel—ovarian cancer	0.000156	0.000912	CcSEcCtD
Prednisone—Face oedema—Doxorubicin—ovarian cancer	0.000156	0.000911	CcSEcCtD
Prednisone—Erythema—Docetaxel—ovarian cancer	0.000156	0.000911	CcSEcCtD
Prednisone—Malnutrition—Docetaxel—ovarian cancer	0.000156	0.000911	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000155	0.000909	CcSEcCtD
Prednisone—Nausea—Topotecan—ovarian cancer	0.000155	0.000905	CcSEcCtD
Prednisone—Discomfort—Paclitaxel—ovarian cancer	0.000155	0.000904	CcSEcCtD
Prednisone—Muscular weakness—Epirubicin—ovarian cancer	0.000154	0.0009	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000154	0.0009	CcSEcCtD
Prednisone—Cardiac arrest—Doxorubicin—ovarian cancer	0.000154	0.000898	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—ovarian cancer	0.000153	0.000894	CcSEcCtD
Prednisone—Diarrhoea—Vinorelbine—ovarian cancer	0.000153	0.000892	CcSEcCtD
Prednisone—Abdominal distension—Epirubicin—ovarian cancer	0.000152	0.000888	CcSEcCtD
Prednisone—Nausea—Melphalan—ovarian cancer	0.000152	0.000887	CcSEcCtD
Prednisone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00015	0.000877	CcSEcCtD
Prednisone—Oedema—Paclitaxel—ovarian cancer	0.00015	0.000877	CcSEcCtD
Prednisone—Infection—Paclitaxel—ovarian cancer	0.000149	0.000871	CcSEcCtD
Prednisone—Dry skin—Doxorubicin—ovarian cancer	0.000148	0.000865	CcSEcCtD
Prednisone—Pancreatitis—Epirubicin—ovarian cancer	0.000148	0.000864	CcSEcCtD
Prednisone—Shock—Paclitaxel—ovarian cancer	0.000148	0.000863	CcSEcCtD
Prednisone—Dizziness—Vinorelbine—ovarian cancer	0.000148	0.000862	CcSEcCtD
Prednisone—Nervous system disorder—Paclitaxel—ovarian cancer	0.000147	0.00086	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—ovarian cancer	0.000147	0.000859	CcSEcCtD
Prednisone—Tachycardia—Paclitaxel—ovarian cancer	0.000146	0.000856	CcSEcCtD
Prednisone—Skin disorder—Paclitaxel—ovarian cancer	0.000146	0.000852	CcSEcCtD
Prednisone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000145	0.000848	CcSEcCtD
Prednisone—Anaemia—Docetaxel—ovarian cancer	0.000144	0.000842	CcSEcCtD
Prednisone—Anorexia—Paclitaxel—ovarian cancer	0.000143	0.000836	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000142	0.000833	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—ovarian cancer	0.000142	0.000833	CcSEcCtD
Prednisone—Vomiting—Vinorelbine—ovarian cancer	0.000142	0.000829	CcSEcCtD
Prednisone—Neutropenia—Epirubicin—ovarian cancer	0.000141	0.000824	CcSEcCtD
Prednisone—Rash—Vinorelbine—ovarian cancer	0.000141	0.000822	CcSEcCtD
Prednisone—Dermatitis—Vinorelbine—ovarian cancer	0.000141	0.000821	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—ovarian cancer	0.000141	0.000821	CcSEcCtD
Prednisone—Headache—Vinorelbine—ovarian cancer	0.00014	0.000817	CcSEcCtD
Prednisone—Syncope—Docetaxel—ovarian cancer	0.00014	0.000817	CcSEcCtD
Prednisone—Weight increased—Epirubicin—ovarian cancer	0.000137	0.000802	CcSEcCtD
Prednisone—Loss of consciousness—Docetaxel—ovarian cancer	0.000137	0.000801	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—ovarian cancer	0.000137	0.0008	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000137	0.000799	CcSEcCtD
Prednisone—Weight decreased—Epirubicin—ovarian cancer	0.000136	0.000798	CcSEcCtD
Prednisone—Hyperglycaemia—Epirubicin—ovarian cancer	0.000136	0.000795	CcSEcCtD
Prednisone—Insomnia—Paclitaxel—ovarian cancer	0.000136	0.000793	CcSEcCtD
Prednisone—Convulsion—Docetaxel—ovarian cancer	0.000135	0.000789	CcSEcCtD
Prednisone—Paraesthesia—Paclitaxel—ovarian cancer	0.000135	0.000788	CcSEcCtD
Prednisone—Hypertension—Docetaxel—ovarian cancer	0.000135	0.000786	CcSEcCtD
Prednisone—Myalgia—Docetaxel—ovarian cancer	0.000133	0.000775	CcSEcCtD
Prednisone—Arthralgia—Docetaxel—ovarian cancer	0.000133	0.000775	CcSEcCtD
Prednisone—Nausea—Vinorelbine—ovarian cancer	0.000133	0.000775	CcSEcCtD
Prednisone—Dyspepsia—Paclitaxel—ovarian cancer	0.000132	0.000772	CcSEcCtD
Prednisone—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000132	0.000771	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000132	0.00077	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—ovarian cancer	0.000131	0.000763	CcSEcCtD
Prednisone—Decreased appetite—Paclitaxel—ovarian cancer	0.00013	0.000762	CcSEcCtD
Prednisone—Prednisolone—ABCB1—ovarian cancer	0.00013	0.0505	CrCbGaD
Prednisone—Fatigue—Paclitaxel—ovarian cancer	0.000129	0.000756	CcSEcCtD
Prednisone—Constipation—Paclitaxel—ovarian cancer	0.000128	0.00075	CcSEcCtD
Prednisone—Betamethasone—ABCB1—ovarian cancer	0.000127	0.0495	CrCbGaD
Prednisone—Oedema—Docetaxel—ovarian cancer	0.000127	0.000743	CcSEcCtD
Prednisone—Anaphylactic shock—Docetaxel—ovarian cancer	0.000127	0.000743	CcSEcCtD
Prednisone—Weight increased—Doxorubicin—ovarian cancer	0.000127	0.000742	CcSEcCtD
Prednisone—Infection—Docetaxel—ovarian cancer	0.000126	0.000739	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—ovarian cancer	0.000126	0.000738	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000126	0.000736	CcSEcCtD
Prednisone—Shock—Docetaxel—ovarian cancer	0.000125	0.000731	CcSEcCtD
Prednisone—Nervous system disorder—Docetaxel—ovarian cancer	0.000125	0.000729	CcSEcCtD
Prednisone—Tachycardia—Docetaxel—ovarian cancer	0.000124	0.000726	CcSEcCtD
Prednisone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000124	0.000723	CcSEcCtD
Prednisone—Skin disorder—Docetaxel—ovarian cancer	0.000124	0.000722	CcSEcCtD
Prednisone—Bradycardia—Epirubicin—ovarian cancer	0.000123	0.000718	CcSEcCtD
Prednisone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000123	0.000717	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000122	0.000713	CcSEcCtD
Prednisone—Haemoglobin—Epirubicin—ovarian cancer	0.000121	0.000709	CcSEcCtD
Prednisone—Anorexia—Docetaxel—ovarian cancer	0.000121	0.000709	CcSEcCtD
Prednisone—Haemorrhage—Epirubicin—ovarian cancer	0.000121	0.000706	CcSEcCtD
Prednisone—Urticaria—Paclitaxel—ovarian cancer	0.000119	0.000697	CcSEcCtD
Prednisone—Connective tissue disorder—Epirubicin—ovarian cancer	0.000119	0.000694	CcSEcCtD
Prednisone—Abdominal pain—Paclitaxel—ovarian cancer	0.000119	0.000693	CcSEcCtD
Prednisone—Body temperature increased—Paclitaxel—ovarian cancer	0.000119	0.000693	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000116	0.000677	CcSEcCtD
Prednisone—Insomnia—Docetaxel—ovarian cancer	0.000115	0.000672	CcSEcCtD
Prednisone—Paraesthesia—Docetaxel—ovarian cancer	0.000114	0.000668	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—ovarian cancer	0.000114	0.000665	CcSEcCtD
Prednisone—Eye disorder—Epirubicin—ovarian cancer	0.000113	0.00066	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—ovarian cancer	0.000112	0.000656	CcSEcCtD
Prednisone—Flushing—Epirubicin—ovarian cancer	0.000112	0.000655	CcSEcCtD
Prednisone—Dyspepsia—Docetaxel—ovarian cancer	0.000112	0.000654	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—ovarian cancer	0.000112	0.000653	CcSEcCtD
Prednisone—Decreased appetite—Docetaxel—ovarian cancer	0.000111	0.000646	CcSEcCtD
Prednisone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000111	0.000646	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00011	0.000642	CcSEcCtD
Prednisone—Fatigue—Docetaxel—ovarian cancer	0.00011	0.000641	CcSEcCtD
Prednisone—Angiopathy—Epirubicin—ovarian cancer	0.00011	0.00064	CcSEcCtD
Prednisone—Immune system disorder—Epirubicin—ovarian cancer	0.000109	0.000637	CcSEcCtD
Prednisone—Constipation—Docetaxel—ovarian cancer	0.000109	0.000636	CcSEcCtD
Prednisone—Arrhythmia—Epirubicin—ovarian cancer	0.000108	0.00063	CcSEcCtD
Prednisone—Asthenia—Paclitaxel—ovarian cancer	0.000108	0.000629	CcSEcCtD
Prednisone—Alopecia—Epirubicin—ovarian cancer	0.000107	0.000624	CcSEcCtD
Prednisone—Pruritus—Paclitaxel—ovarian cancer	0.000106	0.000621	CcSEcCtD
Prednisone—Mental disorder—Epirubicin—ovarian cancer	0.000106	0.000618	CcSEcCtD
Prednisone—Erythema—Epirubicin—ovarian cancer	0.000105	0.000614	CcSEcCtD
Prednisone—Malnutrition—Epirubicin—ovarian cancer	0.000105	0.000614	CcSEcCtD
Prednisone—Feeling abnormal—Docetaxel—ovarian cancer	0.000105	0.000613	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—ovarian cancer	0.000104	0.00061	CcSEcCtD
Prednisone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000104	0.000608	CcSEcCtD
Prednisone—Flushing—Doxorubicin—ovarian cancer	0.000104	0.000606	CcSEcCtD
Prednisone—Diarrhoea—Paclitaxel—ovarian cancer	0.000103	0.0006	CcSEcCtD
Prednisone—Angiopathy—Doxorubicin—ovarian cancer	0.000101	0.000592	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—ovarian cancer	0.000101	0.00059	CcSEcCtD
Prednisone—Abdominal pain—Docetaxel—ovarian cancer	0.000101	0.000588	CcSEcCtD
Prednisone—Body temperature increased—Docetaxel—ovarian cancer	0.000101	0.000588	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—ovarian cancer	9.98e-05	0.000583	CcSEcCtD
Prednisone—Hydrocortisone—ABCB1—ovarian cancer	9.93e-05	0.0386	CrCbGaD
Prednisone—Dizziness—Paclitaxel—ovarian cancer	9.92e-05	0.00058	CcSEcCtD
Prednisone—Vision blurred—Epirubicin—ovarian cancer	9.91e-05	0.000579	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—ovarian cancer	9.87e-05	0.000577	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—ovarian cancer	9.79e-05	0.000572	CcSEcCtD
Prednisone—Ill-defined disorder—Epirubicin—ovarian cancer	9.75e-05	0.00057	CcSEcCtD
Prednisone—Erythema—Doxorubicin—ovarian cancer	9.73e-05	0.000568	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—ovarian cancer	9.73e-05	0.000568	CcSEcCtD
Prednisone—Anaemia—Epirubicin—ovarian cancer	9.71e-05	0.000568	CcSEcCtD
Prednisone—Agitation—Epirubicin—ovarian cancer	9.66e-05	0.000565	CcSEcCtD
Prednisone—Vomiting—Paclitaxel—ovarian cancer	9.54e-05	0.000558	CcSEcCtD
Prednisone—Malaise—Epirubicin—ovarian cancer	9.48e-05	0.000554	CcSEcCtD
Prednisone—Rash—Paclitaxel—ovarian cancer	9.46e-05	0.000553	CcSEcCtD
Prednisone—Dermatitis—Paclitaxel—ovarian cancer	9.45e-05	0.000552	CcSEcCtD
Prednisone—Vertigo—Epirubicin—ovarian cancer	9.44e-05	0.000552	CcSEcCtD
Prednisone—Syncope—Epirubicin—ovarian cancer	9.43e-05	0.000551	CcSEcCtD
Prednisone—Headache—Paclitaxel—ovarian cancer	9.4e-05	0.000549	CcSEcCtD
Prednisone—Hypersensitivity—Docetaxel—ovarian cancer	9.37e-05	0.000548	CcSEcCtD
Prednisone—Loss of consciousness—Epirubicin—ovarian cancer	9.24e-05	0.00054	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—ovarian cancer	9.17e-05	0.000536	CcSEcCtD
Prednisone—Asthenia—Docetaxel—ovarian cancer	9.12e-05	0.000533	CcSEcCtD
Prednisone—Convulsion—Epirubicin—ovarian cancer	9.11e-05	0.000532	CcSEcCtD
Prednisone—Hypertension—Epirubicin—ovarian cancer	9.07e-05	0.00053	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—ovarian cancer	9.02e-05	0.000527	CcSEcCtD
Prednisone—Pruritus—Docetaxel—ovarian cancer	9e-05	0.000526	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—ovarian cancer	8.99e-05	0.000525	CcSEcCtD
Prednisone—Arthralgia—Epirubicin—ovarian cancer	8.95e-05	0.000523	CcSEcCtD
Prednisone—Myalgia—Epirubicin—ovarian cancer	8.95e-05	0.000523	CcSEcCtD
Prednisone—Agitation—Doxorubicin—ovarian cancer	8.94e-05	0.000522	CcSEcCtD
Prednisone—Anxiety—Epirubicin—ovarian cancer	8.92e-05	0.000521	CcSEcCtD
Prednisone—Nausea—Paclitaxel—ovarian cancer	8.91e-05	0.000521	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	8.89e-05	0.000519	CcSEcCtD
Prednisone—Discomfort—Epirubicin—ovarian cancer	8.84e-05	0.000517	CcSEcCtD
Prednisone—Malaise—Doxorubicin—ovarian cancer	8.77e-05	0.000513	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—ovarian cancer	8.74e-05	0.000511	CcSEcCtD
Prednisone—Syncope—Doxorubicin—ovarian cancer	8.72e-05	0.00051	CcSEcCtD
Prednisone—Diarrhoea—Docetaxel—ovarian cancer	8.7e-05	0.000509	CcSEcCtD
Prednisone—Oedema—Epirubicin—ovarian cancer	8.58e-05	0.000501	CcSEcCtD
Prednisone—Anaphylactic shock—Epirubicin—ovarian cancer	8.58e-05	0.000501	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—ovarian cancer	8.55e-05	0.0005	CcSEcCtD
Prednisone—Infection—Epirubicin—ovarian cancer	8.52e-05	0.000498	CcSEcCtD
Prednisone—Shock—Epirubicin—ovarian cancer	8.44e-05	0.000493	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—ovarian cancer	8.43e-05	0.000493	CcSEcCtD
Prednisone—Nervous system disorder—Epirubicin—ovarian cancer	8.41e-05	0.000492	CcSEcCtD
Prednisone—Dizziness—Docetaxel—ovarian cancer	8.41e-05	0.000492	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—ovarian cancer	8.4e-05	0.000491	CcSEcCtD
Prednisone—Tachycardia—Epirubicin—ovarian cancer	8.37e-05	0.000489	CcSEcCtD
Prednisone—Skin disorder—Epirubicin—ovarian cancer	8.33e-05	0.000487	CcSEcCtD
Prednisone—Hyperhidrosis—Epirubicin—ovarian cancer	8.29e-05	0.000485	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—ovarian cancer	8.28e-05	0.000484	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—ovarian cancer	8.28e-05	0.000484	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—ovarian cancer	8.25e-05	0.000482	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	8.22e-05	0.000481	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—ovarian cancer	8.18e-05	0.000478	CcSEcCtD
Prednisone—Anorexia—Epirubicin—ovarian cancer	8.18e-05	0.000478	CcSEcCtD
Prednisone—Vomiting—Docetaxel—ovarian cancer	8.09e-05	0.000473	CcSEcCtD
Prednisone—Rash—Docetaxel—ovarian cancer	8.02e-05	0.000469	CcSEcCtD
Prednisone—Dermatitis—Docetaxel—ovarian cancer	8.01e-05	0.000468	CcSEcCtD
Prednisone—Headache—Docetaxel—ovarian cancer	7.97e-05	0.000466	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—ovarian cancer	7.94e-05	0.000464	CcSEcCtD
Prednisone—Oedema—Doxorubicin—ovarian cancer	7.94e-05	0.000464	CcSEcCtD
Prednisone—Infection—Doxorubicin—ovarian cancer	7.89e-05	0.000461	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	7.82e-05	0.000457	CcSEcCtD
Prednisone—Shock—Doxorubicin—ovarian cancer	7.81e-05	0.000456	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—ovarian cancer	7.78e-05	0.000455	CcSEcCtD
Prednisone—Insomnia—Epirubicin—ovarian cancer	7.76e-05	0.000454	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—ovarian cancer	7.75e-05	0.000453	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—ovarian cancer	7.71e-05	0.000451	CcSEcCtD
Prednisone—Paraesthesia—Epirubicin—ovarian cancer	7.7e-05	0.00045	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—ovarian cancer	7.67e-05	0.000449	CcSEcCtD
Prednisone—Anorexia—Doxorubicin—ovarian cancer	7.57e-05	0.000442	CcSEcCtD
Prednisone—Nausea—Docetaxel—ovarian cancer	7.55e-05	0.000442	CcSEcCtD
Prednisone—Dyspepsia—Epirubicin—ovarian cancer	7.55e-05	0.000441	CcSEcCtD
Prednisone—Decreased appetite—Epirubicin—ovarian cancer	7.46e-05	0.000436	CcSEcCtD
Prednisone—Dexamethasone—ABCB1—ovarian cancer	7.4e-05	0.0288	CrCbGaD
Prednisone—Fatigue—Epirubicin—ovarian cancer	7.4e-05	0.000432	CcSEcCtD
Prednisone—Constipation—Epirubicin—ovarian cancer	7.34e-05	0.000429	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	7.23e-05	0.000423	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—ovarian cancer	7.18e-05	0.00042	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—ovarian cancer	7.13e-05	0.000417	CcSEcCtD
Prednisone—Feeling abnormal—Epirubicin—ovarian cancer	7.07e-05	0.000413	CcSEcCtD
Prednisone—Gastrointestinal pain—Epirubicin—ovarian cancer	7.01e-05	0.00041	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—ovarian cancer	6.99e-05	0.000408	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—ovarian cancer	6.9e-05	0.000403	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—ovarian cancer	6.84e-05	0.0004	CcSEcCtD
Prednisone—Urticaria—Epirubicin—ovarian cancer	6.81e-05	0.000398	CcSEcCtD
Prednisone—Constipation—Doxorubicin—ovarian cancer	6.79e-05	0.000397	CcSEcCtD
Prednisone—Body temperature increased—Epirubicin—ovarian cancer	6.78e-05	0.000396	CcSEcCtD
Prednisone—Abdominal pain—Epirubicin—ovarian cancer	6.78e-05	0.000396	CcSEcCtD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	6.67e-05	0.00183	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—MYC—ovarian cancer	6.63e-05	0.00182	CbGpPWpGaD
Prednisone—Feeling abnormal—Doxorubicin—ovarian cancer	6.54e-05	0.000382	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—ovarian cancer	6.49e-05	0.000379	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.42e-05	0.00176	CbGpPWpGaD
Prednisone—Hypersensitivity—Epirubicin—ovarian cancer	6.32e-05	0.000369	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—ovarian cancer	6.31e-05	0.000369	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—ovarian cancer	6.27e-05	0.000367	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—ovarian cancer	6.27e-05	0.000367	CcSEcCtD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	6.19e-05	0.0017	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	6.16e-05	0.00169	CbGpPWpGaD
Prednisone—Asthenia—Epirubicin—ovarian cancer	6.15e-05	0.00036	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	6.09e-05	0.00167	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—YAP1—ovarian cancer	6.09e-05	0.00167	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CD—ovarian cancer	6.08e-05	0.00167	CbGpPWpGaD
Prednisone—Pruritus—Epirubicin—ovarian cancer	6.07e-05	0.000355	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—ovarian cancer	6.01e-05	0.00165	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	5.9e-05	0.00162	CbGpPWpGaD
Prednisone—ALB—Hemostasis—RAD51C—ovarian cancer	5.88e-05	0.00161	CbGpPWpGaD
Prednisone—Diarrhoea—Epirubicin—ovarian cancer	5.87e-05	0.000343	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—ovarian cancer	5.85e-05	0.000342	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—ovarian cancer	5.72e-05	0.00157	CbGpPWpGaD
Prednisone—Asthenia—Doxorubicin—ovarian cancer	5.69e-05	0.000333	CcSEcCtD
Prednisone—Dizziness—Epirubicin—ovarian cancer	5.67e-05	0.000332	CcSEcCtD
Prednisone—NR3C1—Gene Expression—TTF1—ovarian cancer	5.66e-05	0.00155	CbGpPWpGaD
Prednisone—Pruritus—Doxorubicin—ovarian cancer	5.62e-05	0.000328	CcSEcCtD
Prednisone—Vomiting—Epirubicin—ovarian cancer	5.45e-05	0.000319	CcSEcCtD
Prednisone—ALB—Folate Metabolism—IL2—ovarian cancer	5.45e-05	0.0015	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—ovarian cancer	5.45e-05	0.0015	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	5.44e-05	0.0015	CbGpPWpGaD
Prednisone—Diarrhoea—Doxorubicin—ovarian cancer	5.43e-05	0.000317	CcSEcCtD
Prednisone—Rash—Epirubicin—ovarian cancer	5.41e-05	0.000316	CcSEcCtD
Prednisone—Dermatitis—Epirubicin—ovarian cancer	5.4e-05	0.000316	CcSEcCtD
Prednisone—Headache—Epirubicin—ovarian cancer	5.37e-05	0.000314	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	5.37e-05	0.00147	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	5.36e-05	0.00147	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—PGR—ovarian cancer	5.31e-05	0.00146	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CB—ovarian cancer	5.3e-05	0.00146	CbGpPWpGaD
Prednisone—Dizziness—Doxorubicin—ovarian cancer	5.25e-05	0.000307	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.23e-05	0.00144	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NR5A1—ovarian cancer	5.14e-05	0.00141	CbGpPWpGaD
Prednisone—Nausea—Epirubicin—ovarian cancer	5.1e-05	0.000298	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—ovarian cancer	5.05e-05	0.000295	CcSEcCtD
Prednisone—Rash—Doxorubicin—ovarian cancer	5e-05	0.000293	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—ovarian cancer	5e-05	0.000292	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—CTNNB1—ovarian cancer	4.99e-05	0.00137	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL6—ovarian cancer	4.99e-05	0.00137	CbGpPWpGaD
Prednisone—Headache—Doxorubicin—ovarian cancer	4.97e-05	0.000291	CcSEcCtD
Prednisone—NR3C1—Generic Transcription Pathway—PARP1—ovarian cancer	4.94e-05	0.00136	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	4.9e-05	0.00135	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.89e-05	0.00134	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYTB—ovarian cancer	4.88e-05	0.00134	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—ovarian cancer	4.8e-05	0.00132	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.77e-05	0.00131	CbGpPWpGaD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	4.74e-05	0.0013	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.73e-05	0.0013	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.73e-05	0.0013	CbGpPWpGaD
Prednisone—Nausea—Doxorubicin—ovarian cancer	4.71e-05	0.000276	CcSEcCtD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	4.71e-05	0.00129	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.68e-05	0.00128	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	4.67e-05	0.00128	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	4.59e-05	0.00126	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PTEN—ovarian cancer	4.58e-05	0.00126	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	4.54e-05	0.00125	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.53e-05	0.00125	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	4.47e-05	0.00123	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	4.42e-05	0.00121	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—ovarian cancer	4.39e-05	0.00121	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—STAT3—ovarian cancer	4.35e-05	0.00119	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	4.33e-05	0.00119	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	4.31e-05	0.00118	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—BRIP1—ovarian cancer	4.26e-05	0.00117	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPP1CC—ovarian cancer	4.26e-05	0.00117	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.2e-05	0.00115	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	4.15e-05	0.00114	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.14e-05	0.00114	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CASP3—ovarian cancer	4.14e-05	0.00114	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL2—ovarian cancer	4.14e-05	0.00114	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	4.09e-05	0.00112	CbGpPWpGaD
Prednisone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	4.09e-05	0.00112	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	4.06e-05	0.00111	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	4.05e-05	0.00111	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	4.02e-05	0.00111	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	3.97e-05	0.00109	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—VEGFA—ovarian cancer	3.97e-05	0.00109	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.95e-05	0.00109	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	3.94e-05	0.00108	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	3.8e-05	0.00104	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	3.78e-05	0.00104	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.73e-05	0.00102	CbGpPWpGaD
Prednisone—ALB—Metabolism—NME2—ovarian cancer	3.7e-05	0.00102	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.58e-05	0.000984	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	3.52e-05	0.000965	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—ovarian cancer	3.5e-05	0.000961	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NME2—ovarian cancer	3.32e-05	0.000912	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3.27e-05	0.000899	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NME2—ovarian cancer	3.24e-05	0.00089	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CA—ovarian cancer	3.23e-05	0.000888	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	3.23e-05	0.000887	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL6—ovarian cancer	3.2e-05	0.00088	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.14e-05	0.000862	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SPARC—ovarian cancer	3.14e-05	0.000862	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.14e-05	0.000861	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.11e-05	0.000853	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	3.07e-05	0.000843	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—IL6—ovarian cancer	3.04e-05	0.000834	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	2.95e-05	0.000809	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—YAP1—ovarian cancer	2.93e-05	0.000805	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.9e-05	0.000797	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—YAP1—ovarian cancer	2.86e-05	0.000785	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	2.84e-05	0.000779	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.83e-05	0.000777	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.82e-05	0.000773	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AKT1—ovarian cancer	2.64e-05	0.000725	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	2.63e-05	0.000721	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.59e-05	0.000711	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	2.59e-05	0.000711	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PGR—ovarian cancer	2.56e-05	0.000703	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.56e-05	0.000702	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	2.55e-05	0.000699	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.49e-05	0.000683	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.39e-05	0.000657	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYTB—ovarian cancer	2.38e-05	0.000654	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PARP1—ovarian cancer	2.38e-05	0.000653	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—FASN—ovarian cancer	2.33e-05	0.00064	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.33e-05	0.00064	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.31e-05	0.000634	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.3e-05	0.00063	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC5A5—ovarian cancer	2.29e-05	0.00063	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SOD1—ovarian cancer	2.28e-05	0.000626	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PPP2R1A—ovarian cancer	2.27e-05	0.000623	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	2.26e-05	0.00062	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.25e-05	0.000619	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC2A1—ovarian cancer	2.21e-05	0.000608	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.17e-05	0.000595	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYTB—ovarian cancer	2.14e-05	0.000587	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	2.12e-05	0.000583	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.1e-05	0.000575	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.09e-05	0.000574	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYTB—ovarian cancer	2.09e-05	0.000573	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.09e-05	0.000573	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPP1CC—ovarian cancer	2.08e-05	0.000572	CbGpPWpGaD
Prednisone—ALB—Metabolism—BRIP1—ovarian cancer	2.08e-05	0.000572	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	2.07e-05	0.000569	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.04e-05	0.000561	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.02e-05	0.000556	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NME2—ovarian cancer	2e-05	0.000548	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.99e-05	0.000546	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.97e-05	0.000541	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	1.93e-05	0.00053	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.92e-05	0.000527	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	1.88e-05	0.000517	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.87e-05	0.000514	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.87e-05	0.000513	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.87e-05	0.000513	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—BRIP1—ovarian cancer	1.82e-05	0.000501	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.82e-05	0.000501	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.82e-05	0.000501	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.76e-05	0.000484	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ABCB1—ovarian cancer	1.75e-05	0.00048	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.73e-05	0.000476	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TYMS—ovarian cancer	1.72e-05	0.000471	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CAV1—ovarian cancer	1.67e-05	0.000458	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.67e-05	0.000458	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.64e-05	0.000451	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.6e-05	0.000438	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.59e-05	0.000435	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.56e-05	0.000429	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.56e-05	0.000429	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CG—ovarian cancer	1.52e-05	0.000417	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.52e-05	0.000417	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	1.48e-05	0.000405	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.47e-05	0.000405	CbGpPWpGaD
Prednisone—ALB—Metabolism—YAP1—ovarian cancer	1.4e-05	0.000384	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CAV1—ovarian cancer	1.38e-05	0.00038	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.38e-05	0.00038	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.38e-05	0.000378	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ESR1—ovarian cancer	1.37e-05	0.000375	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.36e-05	0.000374	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.35e-05	0.000372	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CD—ovarian cancer	1.33e-05	0.000367	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.32e-05	0.000363	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.31e-05	0.00036	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYTB—ovarian cancer	1.29e-05	0.000353	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	1.26e-05	0.000346	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—YAP1—ovarian cancer	1.25e-05	0.000344	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.24e-05	0.000341	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—YAP1—ovarian cancer	1.22e-05	0.000336	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.22e-05	0.000334	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CB—ovarian cancer	1.16e-05	0.00032	CbGpPWpGaD
Prednisone—ALB—Metabolism—FASN—ovarian cancer	1.14e-05	0.000313	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.12e-05	0.000309	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.12e-05	0.000309	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.12e-05	0.000309	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC5A5—ovarian cancer	1.12e-05	0.000308	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	1.11e-05	0.000304	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.11e-05	0.000304	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.09e-05	0.0003	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC2A1—ovarian cancer	1.08e-05	0.000297	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—ovarian cancer	1.07e-05	0.000293	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.06e-05	0.000291	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1B1—ovarian cancer	1.04e-05	0.000285	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—FASN—ovarian cancer	1.02e-05	0.000281	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.01e-05	0.000276	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—FASN—ovarian cancer	9.98e-06	0.000274	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC5A5—ovarian cancer	9.81e-06	0.00027	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC2A1—ovarian cancer	9.71e-06	0.000267	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	9.65e-06	0.000265	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.51e-06	0.000261	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC2A1—ovarian cancer	9.48e-06	0.00026	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1B1—ovarian cancer	9.31e-06	0.000256	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPP2R1A—ovarian cancer	9.2e-06	0.000253	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.15e-06	0.000251	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1B1—ovarian cancer	9.09e-06	0.00025	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—ovarian cancer	9.08e-06	0.000249	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NRAS—ovarian cancer	8.97e-06	0.000246	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK3—ovarian cancer	8.59e-06	0.000236	CbGpPWpGaD
Prednisone—ALB—Metabolism—ABCB1—ovarian cancer	8.54e-06	0.000235	CbGpPWpGaD
Prednisone—ALB—Metabolism—TYMS—ovarian cancer	8.39e-06	0.00023	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—ovarian cancer	8.34e-06	0.000229	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	8.26e-06	0.000227	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.22e-06	0.000226	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK1—ovarian cancer	8.17e-06	0.000224	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPP2R1A—ovarian cancer	8.06e-06	0.000221	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—ovarian cancer	7.72e-06	0.000212	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ABCB1—ovarian cancer	7.67e-06	0.000211	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—YAP1—ovarian cancer	7.54e-06	0.000207	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TYMS—ovarian cancer	7.53e-06	0.000207	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TYMS—ovarian cancer	7.35e-06	0.000202	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MAPK3—ovarian cancer	7.31e-06	0.000201	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—ovarian cancer	7.1e-06	0.000195	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—ovarian cancer	7.09e-06	0.000195	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—ovarian cancer	6.86e-06	0.000188	CbGpPWpGaD
Prednisone—ALB—Metabolism—CAV1—ovarian cancer	6.76e-06	0.000186	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HRAS—ovarian cancer	6.56e-06	0.00018	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.46e-06	0.000177	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CG—ovarian cancer	6.16e-06	0.000169	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—FASN—ovarian cancer	6.15e-06	0.000169	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CAV1—ovarian cancer	6.07e-06	0.000167	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.05e-06	0.000166	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CAV1—ovarian cancer	5.92e-06	0.000163	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	5.89e-06	0.000162	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.84e-06	0.00016	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.8e-06	0.000159	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—ovarian cancer	5.79e-06	0.000159	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.6e-06	0.000154	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CG—ovarian cancer	5.53e-06	0.000152	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CD—ovarian cancer	5.41e-06	0.000149	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CG—ovarian cancer	5.39e-06	0.000148	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.96e-06	0.000136	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—ovarian cancer	4.93e-06	0.000135	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CD—ovarian cancer	4.86e-06	0.000133	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—ovarian cancer	4.81e-06	0.000132	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.74e-06	0.00013	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CB—ovarian cancer	4.72e-06	0.00013	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.61e-06	0.000127	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TYMS—ovarian cancer	4.53e-06	0.000124	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.23e-06	0.000116	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.13e-06	0.000114	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—ovarian cancer	4.08e-06	0.000112	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—ovarian cancer	3.66e-06	0.0001	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CAV1—ovarian cancer	3.65e-06	0.0001	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—ovarian cancer	3.57e-06	9.81e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.32e-06	9.13e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.92e-06	8.02e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—ovarian cancer	2.88e-06	7.9e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.58e-06	7.09e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.55e-06	6.99e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.52e-06	6.92e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—ovarian cancer	2.35e-06	6.45e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—ovarian cancer	2.2e-06	6.04e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—ovarian cancer	2.11e-06	5.79e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—ovarian cancer	2.06e-06	5.65e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.55e-06	4.26e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—ovarian cancer	1.27e-06	3.48e-05	CbGpPWpGaD
